Cargando…

Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan

Duchenne muscular dystrophy (DMD) is an X-linked lethal muscle disorder characterized by primary muscle degeneration. Therapeutic strategies for DMD have been extensively explored, and some are in the stage of human clinical trials. Along with the development of new therapies, sensitive outcome meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuraoka, Mutsuki, Aoki, Yoshitsugu, Takeda, Shin’ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Association for Laboratory Animal Science 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614006/ https://www.ncbi.nlm.nih.gov/pubmed/34135266 http://dx.doi.org/10.1538/expanim.21-0072

Ejemplares similares

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
por: Miskew Nichols, Bailey, et al.
Publicado: (2016)

Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment
por: Hayashita-Kinoh, Hiromi, et al.
Publicado: (2020)

Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs
por: Kuraoka, Mutsuki, et al.
Publicado: (2018)

Initial Pulmonary Respiration Causes Massive Diaphragm Damage and Hyper-CKemia in Duchenne Muscular Dystrophy Dog
por: Nakamura, Akinori, et al.
Publicado: (2013)

Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2021)

Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMD(J)): electrocardiographic, echocardiographic, and morphologic studies
por: Yugeta, Naoko, et al.
Publicado: (2006)

Characterization of a novel microRNA, miR-188, elevated in serum of muscular dystrophy dog model
por: Shibasaki, Hiroyuki, et al.
Publicado: (2019)

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
por: Miyatake, Shouta, et al.
Publicado: (2016)

Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2021)

Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy
por: Mizuno, Hideya, et al.
Publicado: (2011)

Inflammatory predisposition predicts disease phenotypes in muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2016)

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2019)

Trends in steroid therapy for Duchenne muscular dystrophy in Japan
por: Takeuchi, Fumi, et al.
Publicado: (2016)

Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression
por: Ohtsuka, Yoshihisa, et al.
Publicado: (2015)

Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMD(J)) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle
por: Yuasa, Katsutoshi, et al.
Publicado: (2008)

Dystrophic muscle distribution in late-stage muscular dystrophy
por: Pilato, Celeste Michelle, et al.
Publicado: (2020)

Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
por: Tsoumpra, Maria K., et al.
Publicado: (2019)

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice
por: Nogami, Ken'ichiro, et al.
Publicado: (2021)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Immortalized Canine Dystrophic Myoblast Cell Lines for Development of Peptide-Conjugated Splice-Switching Oligonucleotides
por: Tone, Yuichiro, et al.
Publicado: (2021)

Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotide
por: Watanabe, Naoki, et al.
Publicado: (2023)

Progress in muscular dystrophy research with special emphasis on gene therapy
por: SUGITA, Hideo, et al.
Publicado: (2010)

Development of Therapeutic RNA Manipulation for Muscular Dystrophy
por: Saifullah,, et al.
Publicado: (2022)

Antisense PMO Found in Dystrophic Dog Model Was Effective in Cells from Exon 7-Deleted DMD Patient
por: Saito, Takashi, et al.
Publicado: (2010)

Mammalian Models of Duchenne Muscular Dystrophy: Pathological Characteristics and Therapeutic Applications
por: Nakamura, Akinori, et al.
Publicado: (2011)

Heterogenetic parabiosis between healthy and dystrophic mice improve the histopathology in muscular dystrophy
por: Lu, Aiping, et al.
Publicado: (2020)

X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation
por: Barthélémy, Inès, et al.
Publicado: (2020)

Macroglossia and less advanced dystrophic change in the tongue muscle of the Duchenne muscular dystrophy rat
por: Yamanouchi, Keitaro, et al.
Publicado: (2022)

Dataset on the mass spectrometry-based proteomic profiling of the kidney from wild type and the dystrophic mdx-4cv mouse model of X-linked muscular dystrophy
por: Dowling, Paul, et al.
Publicado: (2020)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network
por: Shimizu, Reiko, et al.
Publicado: (2016)

Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy
por: Okada, Takashi, et al.
Publicado: (2013)

Profiles of Steroid Hormones in Canine X-Linked Muscular Dystrophy via Stable Isotope Dilution LC-MS/MS
por: Martins-Júnior, Helio A., et al.
Publicado: (2015)

Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle
por: Miyatake, Shouta, et al.
Publicado: (2019)

Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients
por: Hyzewicz, Janek, et al.
Publicado: (2015)

Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride
por: Takizawa, Hotake, et al.
Publicado: (2019)

Development of Multiexon Skipping Antisense Oligonucleotide Therapy for Duchenne Muscular Dystrophy
por: Aoki, Yoshitsugu, et al.
Publicado: (2013)

Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy)
por: Nakamura, Harumasa, et al.
Publicado: (2013)

Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy
por: Alves, Francesca M., et al.
Publicado: (2022)

X-Linked Duchenne-Type Muscular Dystrophy in Jack Russell Terrier Associated with a Partial Deletion of the Canine DMD Gene
por: Brunetti, Barbara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3mrg3rj2lt2laksvm4os58mtfg